Rhumbline Advisers Imago Bio Sciences, Inc. Transaction History

Rhumbline Advisers

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$15.03 - $35.96 $31,578 - $75,551	2,101 Added 6.0%	37,134 $1.34 Million
Q3 2022 Nov 10, 2022	BUY	$14.15 - $19.5 $32,233 - $44,421	2,278 Added 6.95%	35,033 $527,000
Q2 2022 Aug 11, 2022	BUY	$11.81 - $20.92 $175,661 - $311,164	14,874 Added 83.18%	32,755 $439,000
Q1 2022 May 12, 2022	BUY	$16.97 - $25.0 $303,440 - $447,025	17,881 New	17,881 $345,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.